Risk Analysis: BMS Knightsbridge Limited (05863322)

1. Risk Rating: HIGH

Justification: The company is in liquidation with deeply negative net assets of £-460,668 and shareholders' funds of £-909,949 as of March 2021. The registered address is care of an insolvency practitioner (Ad Business Recovery Limited), accounts and confirmation statements are overdue, and the company has experienced a catastrophic financial deterioration over a two-year period. This represents a total loss scenario for equity holders and significant risk for any counterparties.

2. Key Concerns

Concern 1: Insolvency and Liquidation Status

The company's status is recorded as "Liquidation" and its registered address has been transferred to an insolvency practitioner (Ad Business Recovery Limited). Net assets moved from a positive £1,303,288 (2019) to negative £460,668 (2021), indicating the company is balance-sheet insolvent and likely cash-flow insolvent. Shareholders' funds deteriorated from £854,007 to negative £909,949 over the same period—a swing of approximately £1.76M.

Concern 2: Severe Financial Deterioration

The trajectory is deeply troubling: - 2019: Net assets £1,303,288 | Cash £36,382 - 2020: Net assets £75,011 | Cash £77,562 - 2021: Net assets £-460,668 | Cash £31,544

The 2020 accounts showed a reduction in net assets of approximately £1.23M in a single year, and the 2021 accounts showed a further deterioration of approximately £535K. This suggests either significant trading losses, asset write-downs (possibly goodwill/intangibles given the nature of the business), or a combination of both.

Concern 3: Regulatory Compliance Failures

Both annual accounts (due December 2022) and the confirmation statement (due August 2022) are overdue. While this may be expected given the liquidation, it also means no financial information exists beyond March 2021, creating an information vacuum for creditors and other stakeholders. The name change from BEYOND MEDISPA LIMITED to BMS KNIGHTSBRIDGE LIMITED in October 2021—during the period of financial distress—also warrants scrutiny.

3. Positive Indicators

Limited positives exist given the liquidation status; however:

• Historical trading longevity: The company operated for approximately 15 years (2006-2021) before failure, demonstrating the underlying business model had viability for a sustained period.
• Previous financial strength: As recently as 2019, the company held net assets of over £1.3M, suggesting the business once generated meaningful value.
• PSC transparency: The People with Significant Control register identifies Medispa Treatments Limited (owning 75%+ of shares and voting rights) and Miss Kim Pascoe, providing clarity on ownership structure for potential claims or investigations.

4. Due Diligence Notes

Items Requiring Further Investigation:

1. Liquidation details: Determine the type of liquidation (voluntary vs. compulsory), the appointed liquidator, and the status of creditor claims. The liquidator's reports will reveal realisable asset values and likely distributions.

2. Nature of the 2019-2021 collapse: Investigate whether the deterioration was driven by trading losses, COVID-19 impact (the company operated in the personal services/beauty sector), asset impairments, or other factors. The company operated under SIC code 96090 (other service activities) and its previous names (Beyond Medispa, Meritage Skin Care) suggest a beauty/aesthetics business heavily impacted by pandemic restrictions.

3. Related party transactions: Medispa Treatments Limited holds controlling interest. Examine whether intercompany debts, guarantees, or asset transfers occurred that may affect creditor recovery. The discrepancy between net assets (£-460,668) and shareholders' funds (£-909,949) in 2021 suggests approximately £449K in adjustments—potentially prior period errors or reclassifications noted in the accounts.

4. Director conduct: Assess whether Miss Kim Pascoe has director disqualification records or other corporate involvements that have failed. Verify the timing and rationale for the October 2021 name change.

5. Asset realisation values: The 2021 accounts show £191,750 in total assets against £354,622 in liabilities. Determine what portion of assets comprises intangibles (goodwill, development costs) versus tangible recoverable value, as liquidation values typically fall significantly below book values.